Ustekinumab-induced drug eruption resembling lymphocytic infiltration (of Jessner-Kanof) and lupus erythematosus tumidus

British Journal of Clinical Pharmacology

Volumn 81, Issue 4, 2016, Pages 792-794

  Guarneri, Claudio ^a   Lentini, Maria ^a   Polimeni, Giovanni ^a   Giuffrida, Roberta ^a   Cannavò, Serafinella P ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; ETANERCEPT; ETRETIN; HYDROCORTISONE; METHOTREXATE; USTEKINUMAB;

ADULT; BIOPSY; CASE REPORT; DRUG ERUPTION; DRUG WITHDRAWAL; HISTOLOGY; HUMAN; JESSNER KANOF; LETTER; LUPUS ERYTHEMATOSUS; LUPUS ERYTHEMATOSUS TUMIDUS; LYMPHOCYTIC INFILTRATION; MALE; PAPULE; PHOTOTHERAPY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PSORIASIS AREA AND SEVERITY INDEX; PSORIASIS VULGARIS; PSORIATIC ARTHRITIS; RELAPSE; REMISSION; SKIN DEFECT; DIFFERENTIAL DIAGNOSIS; DRUG ERUPTIONS; LUPUS ERYTHEMATOSUS, DISCOID; LYMPHOCYTOSIS; MIDDLE AGED; PSORIASIS; TREATMENT OUTCOME;

DIAGNOSIS, DIFFERENTIAL; DRUG ERUPTIONS; HUMANS; LUPUS ERYTHEMATOSUS, DISCOID; LYMPHOCYTOSIS; MALE; MIDDLE AGED; PSORIASIS; TREATMENT OUTCOME; USTEKINUMAB;

EID: 84952685680     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/bcp.12837     Document Type: Letter

References (10)

1. Talamonti M, Galluzzo M, Bianchi L, Boca AN, Costanzo A, Chimenti S,. What happened after the clinical trials: long-term safety and efficacy of ustekinumab in daily clinical practice. Dermatology 2014; 229: 324-32.
2. Ahronovitz I, Fox LP,. Severe drug-induced dermatoses. Semin Cutan Med Surg 2014; 33: 49-58.
3. Lipsker D, Mitschler A, Grosshans E, Cribier B,. Could Jessner's lymphocytic infiltrate of the skin be a dermal variant of lupus erythematosus? An analysis of 210 cases. Dermatology 2006; 213: 15-22.
4. Kuhn A, Sonntag M, Ruzicka T, Lehmann P, Megahed M,. Histopathologic findings in lupus erythematosus tumidus: review of 80 patients. J Am Acad Dermatol 2003; 48: 901-8.
5. Schepis C, Lentini M, Siragusa M, Batolo D,. ACE-inhibitor-induced drug eruption resembling lymphocytic infiltration (of Jessner-kanof) and lupus erythematosus tumidus. Dermatology 2004; 208: 354-5.
6. Sparsa L, Afif N, Goetz J, Sordet C, Chatelus E, Lipsker D, Sibilia J,. Jessner-Kanof disease induced by leflunomide: a dermal variant of cutaneous lupus? Rheumatol Int 2011; 31: 255-8.
7. Nolden S, Casper C, Kuhn A, Petereit HF,. Jessner-Kanof lymphocytic infiltration of the skin associated with glatiramer acetate. Mult Scler 2005; 11: 245 -8.
8. Caroli UM, Berner D, Schlegel C, Metzler G, Rochen M, Biedermann T,. Lymphocytic infiltration of the skin Jessner-Kanof after treatment with a hydroquinone-containing bleaching cream. Arch Dermatol 2006; 142: 1655-6.
9. Corazza M, Borghi A, Minghetti S, Mantovani L, Gafà E, Virgili A,. Duloxetine-induced pseudolymphoma with features of lymphocytic infiltration of Jessner-Kanof. Acta Derm Venereol 2014; 94: 605-6.
10. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ,. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-45.